| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |